SEC Form 4 · accession 0001104659-16-162787
Cardiff Oncology, Inc. · CRDF
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William J Welch
Officer — CEO · Director
Period of report
Dec 16, 2016
Accepted (ET)
Dec 19, 2016 · 1:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001213037
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 16, 2016 | P | 2,500 | $2.10 | A | 2,500 | D | |
| Common Stock | Dec 16, 2016 | P | 2,250 | $2.086 | A | 4,750 | D |
Table II — derivative securities
No Table II lines on this filing.